Thomas Karasic

15PUBLICATIONS

113CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsGeospatial information systems and geospatial data modelling

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (15)

Sort by Publication Date:

|Aug 10, 2026

Co-Clinical Evaluation of Synthetic Vitamin D and Chemotherapy in Pancreatic Cancer by Integrated Imaging and Molecular Analyses.

|May 25, 2026

Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trial.

|Aug 01, 2024

Classification and Regression Trees to Predict for Survival for Patients With Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab.

Timothy J Brown, Phyllis A Gimotty, Ronac Mamtani

|Jul 09, 2024

Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma.

Jacob E Till, Lee McDaniel, Changgee Chang

|Mar 29, 2024

First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors.

Mark Yarchoan, John D Powderly, Bruno R Bastos

|Dec 05, 2023

Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial.

Jayesh Desai, Guzman Alonso, Se Hyun Kim

Pageof 3

Frequent Collaborators

Peter O'Dwyer

Timothy J Brown

Mark H O'Hara

Ronac Mamtani

Jacob E Till

Yu-Xiao Yang

Erica L Carpenter

Kim A Reiss

Susan M Domchek

Katherine Nathanson

Frequent Collaborators

Peter O'Dwyer

Timothy J Brown

Mark H O'Hara

Ronac Mamtani